Paper680944
Further studies on pharmacology of berberine.
Sabir M and 2 others. Indian J Physiol Pharmacol, 1978. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Further studies on pharmacology of berberine. Papers, record 680944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/680944
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Berberine | Major topic |
| Berberine Alkaloids | Major topic |
| Animals | |
| Blood Pressure | |
| Body Temperature | |
| Cattle | |
| Depression, Chemical | |
| Dogs | |
| Drug Synergism | |
| Electrolytes | |
| Guinea Pigs | |
| Histamine Antagonists | |
| In Vitro Techniques | |
| Male | |
| Muscle, Smooth | |
| Myocardial Contraction | |
| Prostaglandins E | |
| Prostaglandins F | |
| Rabbits | |
| Rats | |
| Sperm Motility |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39021815 | Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies. | J Nutr Metab | 2024 | https://conductscience.org/library/papers/39021815 | PubMed |
| 34285701 | The Effects of Berberis integerrima Fruit Extract on Glycemic Control Parameters in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34285701 | PubMed |
| 26535033 | A review on biological and chemical diversity in Berberis (Berberidaceae). | EXCLI J | 2015 | https://conductscience.org/library/papers/26535033 | PubMed |
| 25561940 | Preventive Effects of Aqueous Extract of Berberis integerrima Bge. Root on Liver Injury Induced by Diabetes Mellitus (Type 1) in Rats. | Iran J Pharm Res | 2015 | https://conductscience.org/library/papers/25561940 | PubMed |
| 25050261 | Aqueous extract of Berberis integerrima root improves renal dysfunction in streptozotocin induced diabetic rats. | Avicenna J Phytomed | 2013 | https://conductscience.org/library/papers/25050261 | PubMed |
| 19104486 | Gastric and duodenal antiulcer activity of alkaloids: a review. | Molecules | 2008 | https://conductscience.org/library/papers/19104486 | PubMed |
| 8448600 | Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit. | Br J Pharmacol | 1993 | https://conductscience.org/library/papers/8448600 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/680944
GET https://conductscience.org/api/papers/v1/680944/authors